Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation

Brain, Behavior, and Immunity

Volumn 52, Issue , 2016, Pages 153-160

  Bersani, Francesco Saverio ^a,b   Wolkowitz, Owen M ^a   Lindqvist, Daniel ^a,c   Yehuda, Rachel ^d,e   Flory, Janine ^d,e   Bierer, Linda M ^d,e   Makotine, Iouri ^d,e   Abu Amara, Duna ^f,g   Coy, Michelle ^a   Reus, Victor I ^a   Epel, Elissa S ^a   Marmar, Charles ^f,g   Mellon, Synthia H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c LUND UNIVERSITY   (Sweden)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Global arginine bioavailability ratio; Inflammation; Nitric oxide; Posttraumatic stress disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ARGININE; C REACTIVE PROTEIN; CITRULLINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; ORNITHINE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; NITRIC OXIDE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CLINICIAN ADMINISTERED POSTTRAUMATIC STRESS DISORDER SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EARLY TRAUMA INVENTORY; GLOBAL ARGININE BIOAVAILABILITY RATIO; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE ASSESSMENT; POSITIVE AND NEGATIVE AFFECT SCHEDULE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; WAR EXPOSURE; BIOAVAILABILITY; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; INFLAMMATION; METABOLISM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; VETERAN;

ADULT; ARGININE; BIOLOGICAL AVAILABILITY; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CITRULLINE; DEPRESSIVE DISORDER; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; NITRIC OXIDE; ORNITHINE; PSYCHIATRIC STATUS RATING SCALES; STRESS DISORDERS, POST-TRAUMATIC; VETERANS;

EID: 84953245769     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.10.015     Document Type: Article

References (52)

1. Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, American Psychiatric Press, Washington. fifth ed.
2. Albucher R.C., Liberzon I. Psychopharmacological treatment in PTSD: a critical review. J. Psychiatr. Res. 2002, 36:355-367.
3. Beck, A.T., Steer, R.A., G.K., B., 1996. Manual for the Beck Depression Inventory-II, Psychological Corporation, San Antonio.
4. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Klauminzer G., Charney D.S., Keane T.M. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav. Ther. 1990, 13:187-188.
5. Blom G. Statistical Estimates and Transformed Beta Variables 1958, John Wiley & Sons, New York.
6. Bremner J.D., Bolus R., Mayer E.A. Psychometric properties of the early trauma inventory-self report. J. Nerv. Ment. Dis. 2007, 195:211-218.
7. Bugajski J. Social stress adapts signaling pathways involved in stimulation of the hypothalamic-pituitary-adrenal axis. J. Physiol. Pharmacol. 1999, 50:367-379.
8. Ceprnja M., Derek L., Unić A., Blazev M., Fistonić M., Kozarić-Kovacić D., Franić M., Romić Z. Oxidative stress markers in patients with post-traumatic stress disorder. Coll. Antropol. 2011, 35(4):1155-1160.
9. Chandra S., Romero M.J., Shatanawi A., Alkilany A.M., Caldwell R.B., Caldwell R.W. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br. J. Pharmacol. 2012, 165:506-519.
10. Chang J.Y., Liu L.Z. Catecholamines inhibit microglial nitric oxide production. Brain Res. Bull. 2000, 52:525-530.
11. Cirino G., Distrutti E., Wallace J.L. Nitric oxide and inflammation. Inflamm. Allergy Drug Targets 2006, 5:115-119.
12. Colasanti M., Persichini T. Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells. Brain Res. Bull. 2000, 52:155-161.
13. Dehaven C.D., Evans A.M., Dai H., Lawton K.A. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J. Cheminform. 2010, 2:9.
14. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17312-17315.
15. Evans A.M., DeHaven C.D., Barrett T., Mitchell M., Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal. Chem. 2009, 81:6656-6667.
16. First M.B. Structured Clinical Interview for DSM-IV Axis I disorders 1997, American Psychiatric Press, Washington.
17. Goubareva I., Gkaliagkousi E., Shah A., Queen L., Ritter J., Ferro A. Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates. Cardiovasc. Res. 2007, 75:793-802.
18. Harris C.W., Edwards J.L., Baruch A., Riley W.A., Pusser B.E., Rejeski W.J., Herrington D.M. Effects of mental stress on brachial artery flow-mediated vasodilation in healthy normal individuals. Am. Heart J. 2000, 139:405-411.
19. Hlatky R., Goodman J.C., Valadka A.B., Robertson C.S. Role of nitric oxide in cerebral blood flow abnormalities after traumatic brain injury. J. Cereb. Blood Flow Metab. 2003, 23:582-588.
20. Huang P.L. ENOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol. Metab. 2009, 20:295-302.
21. Huynh N.N., Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin. Exp. Pharmacol. Physiol. 2006, 33:1-8.
22. Insel T.R., Quirion R. Psychiatry as a clinical neuroscience discipline. JAMA 2005, 294:2221-2224.
23. Jergovic M., et al. Telomere shortening and immune activity in war veterans with posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 54:275-283.
24. Khoshnoodi M., Fakhraei N., Dehpour A.R. Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice. Pharm. Biol. 2015, 53:739-745.
25. Krass M., Wegener G., Vasar E., Volke V. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav. Brain Res. 2011, 218:57-63.
26. Laroux F.S., Pavlick K.P., Hines I.N., Kawachi S., Harada H., Bharwani S., Hoffman J.M., Grisham M.B. Role of nitric oxide in inflammation. Acta Physiol. Scand. 2001, 173:113-118.
27. Levine A.B., Levine L.M., Levine T.B. Posttraumatic stress disorder and cardiometabolic disease. Cardiology 2014, 127:1-19.
28. Li H., Li X., Smerin S.E., Zhang L., Jia M., Xing G., Su Y.A., Wen J., Benedek D., Ursano R. Mitochondrial gene expression profiles and metabolic pathways in the amygdala associated with exaggerated fear in an animal model of PTSD. Front. Neurol. 2014, 5:164.
29. Lindqvist D., et al. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav. Immun. 2014, 42:81-88.
30. Lopez-Figueroa M.O., Day H.E., Akil H., Watson S.J. Nitric oxide in the stress axis. Histol. Histopathol. 1998, 13:1243-1252.
31. Meewisse M.L., Reitsma J.B., de Vries G.J., Gersons B.P., Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br. J. Psychiatry 2007, 191:387-392.
32. Mellon SH, et al. 2015. Mitochondrial Dysfunction and Defective Uptake of Dietary Nutrients in Subjects with Post Traumatic Stress Disorder. In review.
33. Morris C.R., Poljakovic M., Lavrisha L., Machado L., Kuypers F.A., Morris S.M. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am. J. Respir. Crit. Care Med. 2004, 170:148-153.
34. Moss M.B., Brunini T.M., Soares De Moura R., Novaes Malagris L.E., Roberts N.B., Ellory J.C., Mann G.E., Mendes Ribeiro A.C. Diminished L-arginine bioavailability in hypertension. Clin. Sci. (Lond) 2004, 107:391-397.
35. O'Donovan A., Epel E., Lin J., Wolkowitz O., Cohen B., Maguen S., Metzler T., Lenoci M., Blackburn E., Neylan T.C. Childhood trauma associated with short leukocyte telomere length in posttraumatic stress disorder. Biol. Psychiatry 2011, 70:465-471.
36. Ohta T., Masutomi N., Tsutsui N., Sakairi T., Mitchell M., Milburn M.V., Ryals J.A., Beebe K.D., Guo L. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol. Pathol. 2009, 37:521-535.
37. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
38. Persoons J.H., Schornagel K., Breve J., Berkenbosch F., Kraal G. Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently. Am. J. Respir. Crit. Care Med. 1995, 152:619-624.
39. Pupo M.C., Jorge M.R., Schoedl A.F., Bressan R.A., Andreoli S.B., Mello M.F., de Jesus Mari J. The accuracy of the Clinician-Administered PTSD Scale (CAPS) to identify PTSD cases in victims of urban violence. Psychiatry Res. 2011, 185:157-160.
40. Riedel W. Role of nitric oxide in the control of the hypothalamic-pituitary-adrenocortical axis. Zeitschrift für Rheumatologie 2000, 59:36-42.
41. Scott K.M. Depression, anxiety and incident cardiometabolic diseases. Curr. Opin. Psychiatr. 2014, 27:289-293.
42. Shalev I., Entringer S., Wadhwa P.D., Wolkowitz O.M., Puterman E., Lin J., Epel E.S. Stress and telomere biology: a lifespan perspective. Psychoneuroendocrinology 2013, 38:1835-1842.
43. Siervo M., Jackson S.J., Bluck L.J. In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. J. Hypertens. 2011, 29:1515-1527.
44. Sourij H., Meinitzer A., Pilz S., Grammer T.B., Winkelmann B.R., Boehm B.O., Marz W. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. Atherosclerosis 2011, 218:220-225.
45. Southwick S.M., Paige S., Morgan C.A., Bremner J.D., Krystal J.H., Charney D.S. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin. Clin. Neuropsychiatr. 1999, 4:242-248.
46. Su Y.A., et al. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays. Int. J. Biol. Sci. 2008, 4:223-235.
47. Tang W.H., Wang Z., Cho L., Brennan D.M., Hazen S.L. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J. Am. Coll. Cardiol. 2009, 53:2061-2067.
48. Tang W.H., Shrestha K., Wang Z., Troughton R.W., Klein A.L., Hazen S.L. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. J. Card. Fail. 2013, 19:87-93.
49. Tindle H., Davis E., Kuller L. Attitudes and cardiovascular disease. Maturitas 2010, 67:108-113.
50. Watson D., Clark L.A., Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54:1063-1070.
51. Wilson C.B., McLaughlin L.D., Nair A., Ebenezer P.J., Dange R., Francis J. Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS ONE 2013, 8(10):e76146.
52. Yeh C.B., Leckman J., Wan F.J., Shiah I.S., Lu R.B. Characteristics of acute stress symptoms and nitric oxide concentration in young rescue workers in Taiwan. Psychiatry Res. 2002, 112:59-68.